Towards Healthcare
Allergy Diagnostics Market to Culminate USD 16.45 Bn by 2034

Allergy Diagnostics Market Growth Shows Strong Expansion Toward 2034

According to market projections, the global allergy diagnostics market, valued at USD 5.79 billion in 2024, is anticipated to reach USD 16.45 billion by 2034, growing at a CAGR of 10.96% over the next decade. The rising incidence of allergies and technological advancements bolster market growth. North America dominated the global market due to the presence of key players and a robust healthcare infrastructure.

Content

  • Insight Code: 6140
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The allergy diagnostics market is worth USD 6.42 billion in 2025, and by 2034, it is forecasted to hit USD 16.45 billion, registering a CAGR of 10.96% over the decade.

North America is leading the allergy diagnostics market due to the availability of a robust healthcare infrastructure, favorable government support, and the presence of key players.

Some key players include Roche Diagnostics, Beckman Coulter, and Omega Diagnostics.

Key trends include the growing research activities, advancements in diagnostic technologies, and increasing investments.

Asthma and Allergy Foundation of America, Press Information Bureau, National Institute of Health
Any Questions